PROGYNY, INC.
Profile
Company Names
PROGYNY, INC.
AUXOGYN, INC.
AUXOGYN INC
Addresses
99 HUDSON STREET, 7TH FLOOR, NEW YORK, NY 10013
1490 O-BRIEN DRIVE, SUITE A, MENLO PARK, CA 94025
Phone Numbers
212-888-3124
6506412429
Entity Type:
CORPORATION
Industry:
OTHER HEALTH CARE
Year Incorporated:
2008
State Incorporated:
DELAWARE
Total Amount Raised:
$73,122,699.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2016-06-15
$14,773,147.00
$20,000,000.00
$5,226,853.00
Equity
4
2015-03-04
$34,324,111.00
$40,999,999.00
$6,675,888.00
Equity
3
2013-09-06
$5,525,340.00
$9,885,049.00
$4,359,709.00
Equity, Debt
2
2013-07-24
$500,100.00
$2,893,324.00
$2,393,224.00
Equity
1
2012-05-30
$18,000,001.00
$18,000,001.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GINA
BARTASI
EXECUTIVE OFFICER, DIRECTOR
FRED
COHEN
DIRECTOR
PROTEOGENIX INC
| NODALITY INC
| NODALITY, INC.
| QUINTILES TRANSNATIONAL HOLDINGS INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| NOVAQUEST HEALTHCARE INVESTMENT FUND, L.P.
| REVAL HOLDINGS INC
| NOVAQUEST HEALTHCARE INVESTMENT FUND III, L.P.
| BNA CHICAGO LLC
| NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.
| ROKA BIOSCIENCE, INC.
| RAPID MICRO BIOSYSTEMS, INC.
| AUXOGYN, INC.
| CAREDX, INC.
| PROGYNY, INC.
| CELL DESIGN LABS, INC.
| CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, INC.
| VIDA VENTURES, LLC
| VVAG SPECIAL FUND LLC
| ASKLEPIOS BIOPHARMACEUTICAL, INC.
| VV ATREUS SPECIAL FUND LLC
| VIDA VENTURES II, LLC
| VIDA VENTURES II-A, LLC
| ASCEND GENE + CELL THERAPIES LTD.
| FIREFLY NEUROSCIENCE, INC.
| KYVERNA THERAPEUTICS, INC.
| ASCEND ADVANCED THERAPIES GROUP, INC.
| OLLIN BIOSCIENCES, INC.
GREG
GARFIELD
EXECUTIVE OFFICER
SIMEON
GEORGE
DIRECTOR
SEMPRUS BIOSCIENCES CORP
| GENOCEA BIOSCIENCES, INC.
| HTG MOLECULAR DIAGNOSTICS INC
| AUXOGYN INC
| EFFECTOR THERAPEUTICS, INC.
| HTG MOLECULAR DIAGNOSTICS, INC
| AUXOGYN, INC.
| PRINCIPIA BIOPHARMA INC.
| PROGYNY, INC.
| TP THERAPEUTICS, INC.
| CRISPR THERAPEUTICS AG
| SR ONE CO-INVEST I, LLC
| SIMCHA THERAPEUTICS HOLDING COMPANY, LLC
| ADARX PHARMACEUTICALS, INC.
| SR ONE CAPITAL FUND II-B, LP
| SR ONE CAPITAL FUND II-A, LP
| AVENZO THERAPEUTICS, INC.
| REZO THERAPEUTICS, INC.
| SR ONE CAPITAL FUND III, LP
MARK
GUDIKSEN
DIRECTOR
NILESH
KUMAR
DIRECTOR
EDWIN
NEUMANN
EXECUTIVE OFFICER
BETH
SEIDENBERG
DIRECTOR
3-V BIOSCIENCES, INC.
| HX DIAGNOSTICS INC
| IPIERIAN, INC.
| REDBRICK HEALTH CORP
| TESARO, INC.
| AUXOGYN INC
| PRACTICE FUSION INC
| SANTA MARIA BIOTHERAPEUTICS, INC.
| PINTA BIOTHERAPEUTICS, INC.
| NINA BIOTHERAPEUTICS, INC.
| BREATHE TECHNOLOGIES INC
| AUXOGYN, INC.
| FLEXUS BIOSCIENCES, INC.
| LIVONGO HEALTH, INC.
| PROGYNY, INC.
| CELL DESIGN LABS, INC.
| FLX BIO, INC.
| HIXME INSURANCE SOLUTIONS, INC.
| KINSA INC.
| BREATHE ACQUISITION CORP.
| BREATHE TECHNOLOGIES, INC.
| WESTLAKE BIOPARTNERS FUND I, L.P.
| RAPT THERAPEUTICS, INC.
| TMUNITY THERAPEUTICS, INC.
| SAGIMET BIOSCIENCES INC.
| VERA THERAPEUTICS, INC.
| WESTLAKE BIOPARTNERS OPPORTUNITY FUND I, L.P.
| ARSENAL BIOSCIENCES, INC.
| LATIGO BIOTHERAPEUTICS, INC.
| STAR THERAPEUTICS LLC
MARK
WEEKS
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

